Entity Common Stock, Shares Outstanding of ACADIA PHARMACEUTICALS INC from 31 Jul 2011 to 18 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ACADIA PHARMACEUTICALS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2011 to 18 Feb 2026.
  • ACADIA PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding for the quarter ending 18 Feb 2026 was 170,494,613, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ACADIA PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 170,494,613 +3,132,762 +1.9% 18 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 169,181,817 +2,789,926 +1.7% 29 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 168,712,220 +2,836,168 +1.7% 30 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 167,361,851 +2,140,967 +1.3% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 166,391,891 +2,211,514 +1.3% 29 Oct 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 165,876,052 +2,147,193 +1.3% 31 Jul 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 165,220,884 +2,595,505 +1.6% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 164,180,377 +2,249,383 +1.4% 25 Oct 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 163,728,859 +1,885,674 +1.2% 26 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 162,625,379 +1,196,019 +0.74% 26 Apr 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 161,930,994 +1,175,023 +0.73% 21 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 161,843,185 +1,199,901 +0.75% 28 Jul 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 161,429,360 +1,250,324 +0.78% 28 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 160,755,971 +1,777,884 +1.1% 25 Oct 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 160,643,284 +2,962,454 +1.9% 28 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 160,179,036 +4,454,932 +2.9% 27 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 160,047,470 +4,707,803 +3% 10 Feb 2021 10-K 25 Feb 2021 2020 FY
Q3 2020 158,978,087 +4,952,625 +3.2% 22 Oct 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 157,680,830 +13,193,402 +9.1% 22 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 155,724,104 +11,558,181 +8% 22 Apr 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 155,339,667 +11,457,286 +8% 31 Jan 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 154,025,462 +28,950,905 +23% 23 Oct 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 144,487,428 +19,480,705 +16% 24 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 144,165,923 +19,339,954 +15% 24 Apr 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 143,882,381 +19,180,437 +15% 31 Jan 2019 10-K 27 Feb 2019 2018 FY
Q3 2018 125,074,557 +868,920 +0.7% 31 Oct 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 125,006,723 +2,606,417 +2.1% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 124,825,969 +2,779,527 +2.3% 30 Apr 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 124,701,944 +3,294,318 +2.7% 31 Jan 2018 10-K 27 Feb 2018 2017 FY
Q3 2017 124,205,637 +3,091,791 +2.6% 31 Oct 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 122,400,306 +8,394,642 +7.4% 31 Jul 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 122,046,442 +8,883,432 +7.8% 03 May 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 121,407,626 +8,771,169 +7.8% 31 Jan 2017 10-K 28 Feb 2017 2016 FY
Q3 2016 121,113,846 +20,202,221 +20% 31 Oct 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 114,005,664 +13,290,813 +13% 29 Jul 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 113,163,010 +12,865,584 +13% 28 Apr 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 112,636,457 +12,464,738 +12% 29 Jan 2016 10-K 29 Feb 2016 2015 FY
Q3 2015 100,911,625 +1,141,325 +1.1% 30 Oct 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 100,714,851 +1,278,026 +1.3% 31 Jul 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 100,297,426 +1,321,100 +1.3% 30 Apr 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 100,171,719 +8,823,216 +9.7% 30 Jan 2015 10-K 26 Feb 2015 2014 FY
Q3 2014 99,770,300 +8,903,830 +9.8% 31 Oct 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 99,436,825 +10,653,059 +12% 31 Jul 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 98,976,326 +19,811,441 +25% 30 Apr 2014 10-Q 06 May 2014 2014 Q1
Q4 2013 91,348,503 31 Jan 2014 10-K 27 Feb 2014 2013 FY
Q3 2013 90,866,470 +34,244,895 +60% 31 Oct 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 88,783,766 +35,753,757 +67% 31 Jul 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 79,164,885 +26,237,766 +50% 29 Apr 2013 10-Q 07 May 2013 2013 Q1
Q3 2012 56,621,575 +3,820,656 +7.2% 31 Oct 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 53,030,009 +230,403 +0.44% 31 Jul 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 52,927,119 30 Apr 2012 10-Q 08 May 2012 2012 Q1
Q3 2011 52,800,919 31 Oct 2011 10-Q 09 Nov 2011 2011 Q3
Q2 2011 52,799,606 31 Jul 2011 10-Q 10 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.